FundedIQ
Biotechnology

NanoViricides: Funding, Investors & Team (Oct 2026)

NanoViricides, is a nano-biopharmaceutical company whose business goals are to discover, develop and commercialize therapeutics (nanoviricides™) to advance the care of patients suffering from life-threatening viral infections.

www.nanoviricides.com LinkedIn West Haven, United States 1-10 employees
Biopharma Biotechnology Medical B2B
Total raised
$2.0M
Rounds
1
Latest
Undisclosed round
May 2026

NanoViricides has raised $2.0M across 1 funding round on record, the most recent an undisclosed round of $2.0M announced in May 2026.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

NanoViricides Company Profile and Key Stats

Total funding raised
$2.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$2.0M in May 2026
Employees
1-10
reported band
Headquarters
West Haven, United States

Latest funding round on record: May 2026.

NanoViricides Funding Rounds

Date
Round
Amount
Undisclosed round
$2.0M

NanoViricides Founders and Leadership Team

Name
Role
Contact
Anil Diwan
Founder
Locked

Contact details for the NanoViricides team: 1 has a LinkedIn profile.

Start 14-day free trial →

NanoViricides Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,148
$7.5M

NanoViricides' latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like NanoViricides in Biotechnology and West Haven

Companies Similar to NanoViricides

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…

Private Equity —

NanoViricides Funding FAQs

What does NanoViricides do?

NanoViricides, is a nano-biopharmaceutical company whose business goals are to discover, develop and commercialize therapeutics (nanoviricides™) to advance the care of patients suffering from life-threatening viral infections.

How much funding has NanoViricides raised?

NanoViricides has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in May 2026.

When did NanoViricides last raise funding?

NanoViricides' most recent funding round on record is an undisclosed round of $2.0M, announced in May 2026.

Who founded NanoViricides?

FundedIQ lists Anil Diwan (Founder) at NanoViricides.

Where is NanoViricides headquartered?

NanoViricides is based in West Haven, Connecticut, United States.

How many employees does NanoViricides have?

NanoViricides is in the 1-10 employee band.

How does NanoViricides' funding compare to other Biotechnology startups?

NanoViricides' latest round of $2.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's NanoViricides Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NanoViricides is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.